Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Ignyta, Inc. (RXDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/07/2017 8-K Form 8-K - Current report
02/15/2017 8-K Form 8-K - Current report
01/09/2017 8-K Form 8-K - Current report
06/06/2016 8-K Form 8-K - Current report
04/20/2016 8-K Investor presentation
Docs: "Slide Presentation"
02/18/2016 8-K Investor presentation
Docs: "Presentation"
01/11/2016 8-K Investor presentation
Docs: "Slide Presentation, dated January 2016"
11/09/2015 8-K Investor presentation, Quarterly results
Docs: "Ignyta Announces Third Quarter 2015 Company Highlights and Financial Results",
"Poster Presentation",
"Slide Presentation"
03/17/2015 8-K Investor presentation
Docs: "Asset Purchase Agreement, by and between Ignyta, Inc. and Cephalon, Inc",
"Registration Rights Agreement, by and between Ignyta, Inc. and Cephalon, Inc",
"Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva",
"Slide presentation"
01/12/2015 8-K Investor presentation
Docs: "Slide Presentation, dated January 2015"
10/14/2014 8-K Investor presentation
Docs: "Slide Presentation"
09/29/2014 8-K Investor presentation
Docs: "Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress",
"Slide Presentation"
05/30/2014 8-K Investor presentation
Docs: "Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial",
"Presentation"
02/20/2014 8-K Investor presentation
Docs: "Ignyta Announces Presentation of Preliminary Data from RXDX-101 Phase 1/2 Clinical Trial",
"Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy